Fingerprint
Dive into the research topics of 'A Phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A Phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer
Daniel T. Milton, Christopher G. Azzoli, Robert T. Heelan, Ennapadam Venkatraman, Jorge E. Gomez, Mark G. Kris, Lee M. Krug, William Pao, Naiyer A. Rizvi, Megan Dunne, Vincent A. Miller
Research output: Contribution to journal › Article › peer-review
71
Scopus
citations